Current Liabilities Changement Date
Adcock Ingram Holdings ZAR 2.81B 279.84M 2024-12
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Celltrion KRW 3.4T 216.25B 2025-03
Cspc Pharmaceutical CNY 9.63B 801.28M 2024-12
Dianthus Therapeutics USD 18.45M 2.74M 2024-12
Divis Laboratories Ltd 14.52B 1.61B 2025-03
Gilead Sciences USD 11.19B 1.15B 2025-06
Ionis Pharmaceuticals USD 897.24M 646.94M 2025-06
Kangmei Pharma CNY 5.82B 75.51M 2025-03
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Laboratorios Farma EUR 156.65M 115.81M 2024-12
MacroGenics USD 55.53M 3.78M 2024-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 6.37M 3.17M 2024-12
Neuren Pharmaceuticals AUD 45.76M 36.79M 2024-12
Organigram Holdings CAD 68.96M 15.64M 2024-12
Pfizer USD 37.73B 1.27B 2025-06
Pharma Mar EUR 87.78M 8.29M 2025-06
Qiagen NV USD 1.13B 611.37M 2025-06
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 29.06B 3.16B 2025-06
Sarepta Therapeutics USD 919.95M 314.36M 2025-06
Sartorius EUR 1.55B 72.7M 2025-06
Sino Biopharmaceutical CNY 19.56B 2.39B 2024-12
Takeda JPY 2.17T 336.94B 2025-06
Tilray USD 278.52M 15.02M 2024-11
Zz Pientze Pharmaceu 2.32B 49.86M 2025-03


Tectonic Therapeutic Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.